A randomized phase III trial of palonosetron plus dexamethasone (day 1) versus palonosetron plus dexamethasone (day 1-3) in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy, not including a combination of anthracycline plus cyclophosphamide

被引：0
|
作者：
Sasaki, K. [1 ]
Okita, K. [2 ]
Yuki, S. [3 ]
Takahashi, Y. [4 ]
Abe, M. [5 ]
Hatanaka, K. [6 ]
Isobe, H. [7 ]
Sogabe, S. [8 ]
Oba, K. [9 ]
Komatsu, Y. [10 ]
机构：
[1] Otaru Ekisaikai Hosp, Otaru, Hokkaido, Japan
[2] Sapporo Med Univ Hosp, Sapporo, Hokkaido, Japan
[3] Hokkaido Univ Hosp, Sapporo, Hokkaido 060, Japan
[4] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
[5] Sapporo Kosei Gen Hosp, Sapporo, Hokkaido, Japan
[6] Hakodate Municipal Hosp, Hakodate, Hokkaido, Japan
[7] KKR Sapporo Med Ctr, Sapporo, Hokkaido, Japan
[8] Kushiro Rosai Hosp, Kushiro, Hokkaido, Japan
[9] Hokkaido Univ Hosp, Translat Res & Clin Trial Ctr, Sapporo, Hokkaido 060, Japan
[10] Hokkaido Univ Hosp, Ctr Canc, Sapporo, Hokkaido 060, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1303
引用
收藏
页码：S267 / S268
页数：2
相关论文
共 50 条
  • [31] Palonosetron plus dexamethasone in highly emetogenic chemotherapy: pooled data from two Phase III trials
    Celio, Luigi
    Agustoni, Francesco
    Ricchini, Francesca
    Dotti, Katia
    Niger, Monica
    De Braud, Filippo
    FUTURE ONCOLOGY, 2013, 9 (10) : 1451 - 1458
  • [32] Efficacy of palonosetron and 1-day dexamethasone in moderately emetogenic chemotherapy compared with fosaprepitant, granisetron, and dexamethasone: a prospective randomized crossover study
    Hiromitsu Kitayama
    Yasushi Tsuji
    Junko Sugiyama
    Ayako Doi
    Tomohiro Kondo
    Michiaki Hirayama
    International Journal of Clinical Oncology, 2015, 20 : 1051 - 1056
  • [33] Generic Netupitant Plus Palonosetron and Dexamethasone for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting (CINV) in Cancer Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Retrospective Study
    Simhadri, Soumya
    Dayyala, Sowmya
    Musinipally, Anjani Devi
    Guram, Lavanya
    Madavi, Mamatha
    Kancha, Ramakrishna
    Puligundla, Krishna Chaitanya
    SOUTH ASIAN JOURNAL OF CANCER, 2024,
  • [34] Palonosetron in combination with 1-day versus 3-day dexamethasone to prevent nausea and vomiting in patients receiving paclitaxel and carboplatin
    Naoto Furukawa
    Seiji Kanayama
    Yasuhito Tanase
    Fuminori Ito
    Supportive Care in Cancer, 2015, 23 : 3317 - 3322
  • [35] Palonosetron in combination with 1-day versus 3-day dexamethasone to prevent nausea and vomiting in patients receiving paclitaxel and carboplatin
    Furukawa, Naoto
    Kanayama, Seiji
    Tanase, Yasuhito
    Ito, Fuminori
    SUPPORTIVE CARE IN CANCER, 2015, 23 (11) : 3317 - 3322
  • [36] Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following paclitaxel and carboplatin in patients with gynecologic cancers: A randomized, multicenter, phase-II trial
    Matsuura, Motoki
    Satohisa, Seiro
    Teramoto, Mizue
    Tanaka, Ryoichi
    Iwasaki, Masahiro
    Nishikawa, Akira
    Mizunuma, Masahiro
    Tanaka, Satoshi
    Hayakawa, Osamu
    Saito, Tsuyoshi
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2015, 41 (10) : 1607 - 1613
  • [37] Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting
    Kang, Jin Hyoung
    Kwon, Jung Hye
    Lee, Yun-Gyoo
    Park, Keon Uk
    An, Ho Jung
    Sohn, Joohyuk
    Seol, Young Mi
    Lee, Hyunwoo
    Yun, Hwan-Jung
    Ahn, Jin Seok
    Yang, Ji Hyun
    Song, Hunho
    Koo, Dong-Hoe
    Kim, Jin Young
    Kim, Gun Min
    Kim, Hwa Jung
    CANCER RESEARCH AND TREATMENT, 2020, 52 (03): : 907 - 916
  • [38] Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial. (vol 10, pg 115, 2009)
    Saito, M.
    Aogi, K.
    Sekine, I
    LANCET ONCOLOGY, 2010, 11 (03): : 226 - 226
  • [39] Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy
    Grunberg, Steven M.
    Dugan, Matthew
    Muss, Hyman
    Wood, Marie
    Burdette-Radoux, Susan
    Weisberg, Tracey
    Siebel, Marisa
    SUPPORTIVE CARE IN CANCER, 2009, 17 (05) : 589 - 594
  • [40] Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy
    Steven M. Grunberg
    Matthew Dugan
    Hyman Muss
    Marie Wood
    Susan Burdette-Radoux
    Tracey Weisberg
    Marisa Siebel
    Supportive Care in Cancer, 2009, 17
12345